Study identifier:NIS-RGR-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
A cross sectional study for the assessment of the words used by patients and physicians to express asthma symptoms and the limitations of daily activities in primary care. The " Asthma Language " survey
asthma
N/A
No
-
All
695
Observational
N/A
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.
Location
Location
Patras, Achaia, Greece
Location
Naupaktos, Aitoloakarnania, Greece
Location
Agrinio, Aitoloakarnanias, Greece
Location
Thermo, Aitoloakarnanias, Greece
Location
Argos, Argolida, Greece
Location
Arta, Artas, Greece
Location
Athens, Attiki, Greece
Location
Peraious, Attiki, Greece
Arms | Assigned Interventions |
---|---|
Asthma Language between patients and physicians | - |
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.